ArticleBioscience reports2019

Reversal of EGFR inhibitors' resistance by co-delivering EGFR and integrin αvβ3 inhibitors with nanoparticles in non-small cell lung cancer.

Fei He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.